Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial (Nature Cancer, (2026), 10.1038/s43018-026-01199-y)

Bunse L, Lindner K, Wick A, Freitag A, Lanz LM, Edelmann D, Suwala A, Breckwoldt MO, Harting I, Sahm F, Schlenk RF, Schmitt A, Schnell O, Hense J, Misch M, Krex D, Denk M, Walz J, Steinbach JP, von Deimling A, Schmitt M, Bunse T, Tabatabai G, Bendszus M, Poschke I, Wick W, Platten M (2026)


Publication Type: Journal article, Erratum

Publication year: 2026

Journal

Book Volume: 7

Pages Range: 1322-

Journal Issue: 8

DOI: 10.1038/s43018-026-01227-x

Abstract

Correction to: Nature Cancerhttps://doi.org/10.1038/s43018-026-01199-y, published online 1 July 2026. In the version of the article initially published, in the Abstract, the sentence “The 8-year progression-free and overall survival (OS) rates were 0.42 months (confidence interval (CI): 0.24–0.59) and 0.66 months (CI: 0.46–0.79), respectively” should have read “The 8-year progression-free and overall survival (OS) rates were 0.42 (confidence interval (CI): 0.24–0.59) and 0.66 (CI: 0.46–0.79), respectively”. This correction has been made to the HTML and PDF versions of the article.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Bunse, L., Lindner, K., Wick, A., Freitag, A., Lanz, L.M., Edelmann, D.,... Platten, M. (2026). Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial (Nature Cancer, (2026), 10.1038/s43018-026-01199-y). Nature Cancer, 7(8), 1322-. https://doi.org/10.1038/s43018-026-01227-x

MLA:

Bunse, Lukas, et al. "Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial (Nature Cancer, (2026), 10.1038/s43018-026-01199-y)." Nature Cancer 7.8 (2026): 1322-.

BibTeX: Download